3 studies found for:    11773181 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Tumor Registry of Advanced Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention:
2 Active, not recruiting Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors
Conditions: Metastatic Renal Cell Carcinoma;   Advanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Intervention: Drug: Association of Bevacizumab (BVC)+ Pazopanib (PZP)
3 Recruiting Chemokines and Renal Cancer
Conditions: Carcinoma;   Carcinoma Renal Cell;   Kidney Neoplasms;   Kidney Diseases;   Chemokines
Intervention: Biological: Biological sample

Indicates status has not been verified in more than two years